Maravai LifeSciences Holdings, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Maravai LifeSciences Holdings, Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was -$2.06M, a 750.95% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was -$3.89M.
- Maravai LifeSciences Holdings, Inc. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $30.00K.
- Maravai LifeSciences Holdings, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was -$130.00K.
- Maravai LifeSciences Holdings, Inc. stock issued during period, value, new issues for fiscal 2025 was -$4.84M.
- Maravai LifeSciences Holdings, Inc. stock issued during period, value, new issues for fiscal 2024 was -$1.97M, a 1731.40% decline from fiscal 2023.
- Maravai LifeSciences Holdings, Inc. stock issued during period, value, new issues for fiscal 2023 was $121.00K, a 94.75% decline from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. stock issued during period, value, new issues for fiscal 2022 was $2.31M, a 38.02% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | -$2.06M 10-Q · filed 2026-08-07 | -$6.05M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$3.89M 10-Q · filed 2026-05-08 | -$3.68M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$4.84M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$130.00K 10-Q · filed 2025-11-07 | -$4.92M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $316.00K 10-Q · filed 2026-08-07 | -$5.17M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$5.06M 10-Q · filed 2026-05-08 | -$5.16M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.97M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$382.00K 10-Q · filed 2025-11-07 | -$1.60M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $326.00K 10-Q · filed 2025-08-11 | -$1.46M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$1.87M 10-Q · filed 2025-05-12 | -$811.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $327.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $121.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | -$242.00K 10-Q · filed 2024-11-12 | $926.00K derived: sum of 4 quarters · filed 2025-03-18 |
| 2023-06-30 | $976.00K 10-Q · filed 2024-08-08 | $1.19M derived: sum of 4 quarters · filed 2025-03-18 |
| 2023-03-31 | -$940.00K 10-Q · filed 2024-05-09 | $1.33M derived: sum of 4 quarters · filed 2025-03-18 |
| 2022-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $2.31M 10-K · filed 2025-03-18 |
| 2022-09-30 | $25.00K 10-Q · filed 2023-11-08 | $2.06M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $1.11M 10-Q · filed 2023-08-08 | $2.03M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $34.00K 10-Q · filed 2023-05-09 | $1.70M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $885.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.67M 10-K · filed 2024-02-29 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | |
| 2021-06-30 | $785.00K 10-Q · filed 2022-08-05 |